リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Impact of resting heart rate on cardiovascular mortality according to serum albumin levels in a 24-year follow-up study on a general Japanese population : NIPPON DATA80 (本文)」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Impact of resting heart rate on cardiovascular mortality according to serum albumin levels in a 24-year follow-up study on a general Japanese population : NIPPON DATA80 (本文)

Liu, Yiwei 慶應義塾大学

2022.03.23

概要

Background:
Elevated resting heart rate (RHR) is associated with an increased risk of cardiovascular disease (CVD) and allcause mortality. However, the findings of cohort studies differed. Thus, the impact of RHR on CVD mortality might be different according to the background of the population. Therefore, we examined the relationship of RHR and CVD mortality according to serum albumin (ALB) levels in a Japanese general population.

Methods:
In total, 8,363 individuals without a history of CVD were followed for 24.0 years. The participants were divided into four groups according to the quartiles of RHR (Q1–Q4), and they were further classified into the high and low ALB groups based on a median value of 44 g=L. We estimated the multivariable-adjusted hazard ratios (HRs) of CVD mortality in each RHR group based on ALB levels, and the interaction between RHR and ALB groups on CVD mortality was evaluated.

Results:
We found no significant association between RHR and CVD mortality. However, the Q4 of RHR was significantly associated with an increased risk for CVD mortality (HR 1.27; 95% confidence interval [CI], 1.02–1.57) in participants with a low ALB level. Meanwhile, the Q4 of RHR was significantly correlated with a decreased risk for CVD morality in those with a high ALB level (HR 0.61; 95% CI, 0.47–0.79) after adjusting for covariates. A significant interaction between RHR and ALB for CVD mortality was shown (P < 0.001).

Conclusions:
The impact of RHR on CVD mortality differed according to ALB levels in a general Japanese population.

論文の公開元へ

関連論文

関連論文をもっと見る

参考文献

1. Cooney MT, Vartiainen E, Laatikainen T, Juolevi A, Dudina A, Graham IM. Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women. Am Heart J. 2010 Jul;160(1):208.

2. Huang YQ, Shen G, Huang JY, Zhang B, Feng YQ. A nonlinear association between resting heart rate and ischemic stroke among community elderly hypertensive patients. Postgrad Med. 2020; 132(2):215–219.

3. Parikh KS, Greiner MA, Suzuki T, et al. Resting heart rate and longterm outcomes among the African American population insights from the Jackson Heart Study. JAMA Cardiol. 2017;2(2):172–180.

4. Nwabuo CC, Appiah D, Moreira HT, et al. Temporal changes in resting heart rate, left ventricular dysfunction, heart failure and cardiovascular disease: CARDIA Study. Am J Med. 2020;133(8): 946–953.

5. Zhang M, Han C, Wang C, et al. Association of resting heart rate and cardiovascular disease mortality in hypertensive and normotensive rural Chinese. J Cardiol. 2017;69(5):779–784.

6. Chen XJ, Barywani SB, Hansson PO, et al. Impact of changes in heart rate with age on all-cause death and cardiovascular events in 50-year-old men from the general population. Open Heart. 2019; 6(1):e000856.

7. Custodis F, Roggenbuck U, Lehmann N, et al. Resting heart rate is an independent predictor of all-cause mortality in the middle aged general population. Clin Res Cardiol. 2016;105(7):601–612.

8. Münzel T, Hahad O, Gori T, et al. Heart rate, mortality, and the relation with clinical and subclinical cardiovascular diseases: results from the Gutenberg Health Study. Clin Res Cardiol. 2019;108(12): 1313–1323.

9. Palatini P, Benetos A, Grassi G, et al. Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension. J Hypertens. 2006;24(4):603– 610.

10. Palatini P. Role of elevated heart rate in the development of cardiovascular disease in hypertension. Hypertension. 2011;58(5): 745–750.

11. Bangalore S, Messerli FH, Kostis JB, Pepine CJ. Cardiovascular protection using beta-blockers: a critical review of the evidence. J Am Coll Cardiol. 2007;50(7):563–572.

12. Hara K, Floras JS. After-effects of exercise on haemodynamics and muscle sympathetic nerve activity in young patients with dilated cardiomyopathy. Heart. 1996;75(6):602–608.

13. Carter JR, Kupiers NT, Ray CA. Neurovascular responses to mental stress. J Physiol. 2005;564(Pt 1):321–327.

14. Catai AM, Chacon-Mikahil MP, Martinelli FS, et al. Effects of aerobic exercise training on heart rate variability during wakefulness and sleep and cardiorespiratory responses of young and middle-aged healthy men. Braz J Med Biol Res. 2002;35(6):741–752.

15. Ota A, Kondo N, Murayama N, Tanabe N, Shobugawa Y, Kondo K; Japan Gerontological Evaluation Study (JAGES) group. Serum albumin levels and economic status in Japanese older adults. PLoS Impact of Resting Heart Rate on CVD Mortality 8 j J Epidemiol 2023 One. 2016;11(6):e0155022.

16. Hogg N. Biological chemistry and clinical potential of S-nitrosothiols. Free Radic Biol Med. 2000;28(10):1478–1486.

17. Johnson TA, Stasko NA, Matthews JL, et al. Reduced ischemia= reperfusion injury via glutathione-initiated nitric oxide-releasing dendrimers. Nitric Oxide. 2010;22(1):30–36.

18. Arques S. Human serum albumin in cardiovascular diseases. Eur J Intern Med. 2018;52:8–12.

19. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J. 2004;25(5): 363–370.

20. Park SK, Tucker KL, O’Neill MS, et al. Fruit, vegetable, and fish consumption and heart rate variability: the Veterans Administration Normative Aging Study. Am J Clin Nutr. 2009;89(3):778–786.

21. Hisamatsu T, Miura K, Ohkubo T, et al. High long-chain n-3 fatty acid intake attenuates the effect of high resting heart rate on cardiovascular mortality risk: a 24-year follow-up of Japanese general population. J Cardiol. 2014;64(3):218–224.

22. Okamura T, Hayakawa T, Kadowaki T, et al; NIPPON DATA80 research group. A combination of serum low albumin and aboveaverage cholesterol level was associated with excess mortality. J Clin Epidemiol. 2004;57(11):1188–1195.

23. Okamura T, Hayakawa T, Kadowaki T, et al; NIPPONDATA80 Research Group. Resting heart rate and cause-specific death in a 16.5-year cohort study of the Japanese general population. Am Heart J. 2004;147(6):1024–1032.

24. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.

25. Shigetoh Y, Adachi H, Yamagishi S, et al. Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population. Am J Hypertens. 2009;22(2):151–155.

26. Inoue T, Iseki K, Iseki C, Kinjo K, Ohya Y, Takishita S. Higher heart rate predicts the risk of developing hypertension in a normotensive screened cohort. Circ J. 2007;71(11):1755–1760.

27. McAlister FA, Wiebe N, Ezekowitz JA, Leung AA, Armstrong PW. Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure. Ann Intern Med. 2009;150(11):784–794.

28. Palatini P, Rosei EA, Casiglia E, et al. Management of the hypertensive patient with elevated heart rate: Statement of the Second Consensus Conference endorsed by the European Society of Hypertension. J Hypertens. 2016;34(5):813–821.

29. Brown-Tortorici AR, Naderi N, Tang Y, et al. Serum albumin is incrementally associated with increased mortality across varying levels of kidney function. Nutrition. 2020;79–80:110818.

30. Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC. Albumin levels predict survival in patients with systolic heart failure. Am Heart J. 2008;155(5):883–889.

31. Prenner SB, Pillutla R, Yenigalla S, et al. Serum albumin is a marker of myocardial fibrosis, adverse pulsatile aortic hemodynamics, and prognosis in heart failure with preserved ejection fraction. J Am Heart Assoc. 2020;9(3):e014716.

32. Kanda H, Kita Y, Okamura T, et al. What factors are associated with high plasma B-type natriuretic peptide levels in a general Japanese population? J Hum Hypertens. 2005;19(2):165–172.

33. Kontush A, Chantepie S, Chapman MJ. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler Thromb Vasc Biol. 2003;23(10):1881–1888.

34. Pinchuk I, Lichtenberg D. The mechanism of action of antioxidants against lipoprotein peroxidation, evaluation based on kinetic experiments. Prog Lipid Res. 2002;41(4):279–314.

35. Kayapinar O, Ozde C, Kaya A. Relationship between the reciprocal change in inflammation-related biomarkers (fibrinogen-to-albumin and hsCRP-to-albumin ratios) and the presence and severity of coronary slow flow. Clin Appl Thromb Hemost. 2019;25: 1076029619835383.

36. Umeki Y, Adachi H, Enomoto M, et al. Serum albumin and Cerebrocardiovascular mortality during a 15-year study in a communitybased cohort in Tanushimaru, a cohort of the seven countries study. Intern Med. 2016;55(20):2917–2925.

37. Williams B, Lacy PS, Thom SM, et al; CAFE Investigators; AngloScandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure–lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113(9):1213–1225.

38. Inoue T, Arima H, Katsuimata Y, et al. Development of electrocardiographic left ventricular hypertrophy and resting heart rate over time: findings from the OGHMA Study. Angiology. 2020; 71(1):70–76.

39. Reule S, Drawz PE. Heart rate and blood pressure: any possible implications for management of hypertension? Curr Hypertens Rep. 2012;14(6):478–484.

40. London GM, Blacher J, Pannier B, et al. Arterial wave reflections and survival in end-stage renal failure. Hypertension. 2001;38(3): 434–438.

41. Protogerou AD, Papaioannou TG, Blacher J, et al. Central blood pressures: do we need them in the management of cardiovascular disease? Is it a feasible therapeutic target? J Hypertens. 2007;25(2): 265–272.

42. Papaioannou TG, Vlachopoulos CV, Alexopoulos NA, et al. The effect of heart rate on wave reflections may be determined by the level of aortic stiffness: clinical and technical implications. Am J Hypertens. 2008;21(3):334–340.

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文
を
一発検索！

この論文の関連論文を見る